Related Experiment Video
Updated: May 23, 2026

Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
Published on: January 8, 2020
[The properties of the Pseudomonas aeruginosa bacteriophage phiPMG1]
Abstract:
The properties of the isolated Pseudomonas aeruginosa bacteriophage phiPMG1 include the lytic infection cycle, and the formation of a broad halo (semi-transparent zone) around the plaques. We consider phiPMG1 as a potential member of therapeutic cocktails of live phages, and as a source of peptidoglycan and lipopolysaccharide degrading enzymes. Partial sequencing of phiPMG1 genome has revealed high similarity with known temperate P. aeruginosa phage D3. An open reading frame encoding lytic transglycosilase was identified in the genome. This enzyme PMG MUR was obtained in recombinant form, and its activity and substrate specificity has been studied.
Insights
Pseudomonas aeruginosa bacteriophage phiPMG1 exhibits a lytic cycle and produces enzymes. This phage is a potential therapeutic agent and a source of valuable enzymes for degrading bacterial cell walls.
Area of Science:
- Microbiology
- Virology
- Biochemistry
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen.
- Bacteriophages are viruses that infect bacteria and are explored for therapeutic applications.
- Phage phiPMG1, isolated from P. aeruginosa, shows lytic properties and potential for enzyme discovery.
Purpose of the Study:
- To characterize the properties of Pseudomonas aeruginosa bacteriophage phiPMG1.
- To evaluate phiPMG1 as a potential therapeutic agent and enzyme source.
- To identify and characterize enzymes encoded by the phiPMG1 genome.
Main Methods:
- Isolation and characterization of bacteriophage phiPMG1.
- Analysis of plaque morphology and lytic activity.
- Partial genome sequencing of phiPMG1.
- Identification and recombinant expression of a lytic transglycosilase (PMG MUR).
- Biochemical assays to determine enzyme activity and substrate specificity.
Main Results:
- Phage phiPMG1 demonstrated a lytic infection cycle with characteristic halo formation around plaques.
- Genome sequencing revealed similarity to P. aeruginosa phage D3 and identified an open reading frame for lytic transglycosilase.
- The recombinant enzyme PMG MUR was successfully produced and its activity and substrate specificity were investigated.
Conclusions:
- Phage phiPMG1 is a lytic bacteriophage with potential applications in phage therapy and as a source of peptidoglycan-degrading enzymes.
- The identified lytic transglycosilase, PMG MUR, represents a novel enzyme with potential biotechnological applications.
More Related Videos
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Plasmids

